Excision Margins for Nonmelanotic Skin Cancer

Scientific evidence for advisable excision margins for nonmelanotic skin carcinoma is poorly documented. Recommended excision margins vary from 2 to 15 mm. A prospective study was performed on 150 skin lesions excised over a 9-month period in an outpatient facility at the authors’ institution. Primary nonmelanotic skin lesions were clinically diagnosed as either basal cell carcinoma (nodular, superficial, infiltrating, or sclerosing) or squamous cell carcinoma (well, moderately, or poorly differentiated). Macroscopic surgical excision margins were individually assessed, measured, and excised. Histopathologic analysis was then independently performed to determine the correct diagnosis and to measure the actual microscopic lateral and deep excision margins. Sixty-one percent of lesions were basal cell carcinoma, 25 percent were squamous cell carcinoma, and 15 percent were benign or premalignant. Diagnostic accuracy was 81 percent for basal cell and 59 percent for squamous cell carcinoma. The average diameter of the basal cell carcinoma was 12.1 mm; 47 percent of these lesions had a diameter of less than 10 mm. The average diameter of the squamous cell carcinoma was 16.9 mm; 26 percent of these lesions had a diameter of less than 10 mm. The mean surgical margin was 4.2 mm (3.2 mm adjusted for shrinkage), whereas the mean microscopic lateral margin was 3.4 mm. Overall, complete excision was achieved for 98 percent of basal cell carcinoma and 100 percent of squamous cell carcinoma. The raw data were analyzed to assess the suitability of 1-, 2-, 3-, or 4-mm surgical excision margins. A 4-mm surgical margin would give a microscopic lateral margin beyond one microscopic high-power field (0.5 mm) in 96 percent of cases of basal cell carcinoma and in 97 percent of cases of squamous cell carcinoma. The authors recommend a 4-mm surgical margin as the optimal treatment for skin lesions clinically diagnosed as basal cell or squamous cell carcinoma that are suitable for excision in an outpatient facility. Well-demarcated lesions, such as a nodular basal cell carcinoma, may be excised with a 3-mm margin.

[1]  C. Gooding,et al.  Significance of marginal extension in excised basal-cell carcinoma. , 1965, The New England journal of medicine.

[2]  P. Robins Mohs micrographic surgery. , 1993, The Journal of dermatologic surgery and oncology.

[3]  Fei Liu,et al.  A management approach to incompletely excised basal cell carcinomas of skin. , 1991, International journal of radiation oncology, biology, physics.

[4]  L. Sussman,et al.  Incompletely excised basal cell carcinoma: a management dilemma? , 1996, The Australian and New Zealand journal of surgery.

[5]  W. Grabb,et al.  Statistical evaluation of the treatment of basal cell and squamous cell carcinoma. , 1969, University of Michigan Medical Center journal.

[6]  H. Zarem,et al.  Recurrent basal cell carcinoma. A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. , 1980, Plastic and reconstructive surgery.

[7]  I. McGregor,et al.  Cancer of the Face and Mouth: Pathology and Management for Surgeons , 1986 .

[8]  J. Rippey,et al.  Incompletely excised basal cell carcinomas of the skin , 1997, The Medical journal of Australia.

[9]  R. Pascal,et al.  PROGNOSIS OF “INCOMPLETELY EXCISED” VERSUS “COMPLETELY EXCISED” BASAL CELL CARCINOMA , 1968, Plastic and reconstructive surgery.

[10]  R. Pearl,et al.  An Economic Analysis of Health Care Reform and Its Implications for Plastic Surgery , 1997, Plastic and reconstructive surgery.

[11]  E. Epstein How accurate is the visual assessment of basal carcinoma margins? , 1973, The British journal of dermatology.

[12]  M. Spira,et al.  Basal Cell Carcinoma: A Statistical Approach to Rational Management , 1967, Plastic and reconstructive surgery.

[13]  P. Robins,et al.  Mohs' surgery--fresh tissue technique. , 1975, The Journal of dermatologic surgery.

[14]  S. Salasche,et al.  Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. , 1981, The Journal of dermatologic surgery and oncology.

[15]  R. Jackson,et al.  Horrifying basal cell carcinoma: A study of 33 cases and a comparison with 435 non‐horror cases and a report on four metastatic cases , 1973, Journal of surgical oncology.

[16]  W. I. Cottel,et al.  Mohs' surgery, fresh-tissue technique. Our technique with a review. , 1982, The Journal of dermatologic surgery and oncology.

[17]  T. Tromovitch,et al.  Microscopically Controlled Excision of Skin Tumors: Chemosurgery (Mohs): Fresh Tissue Technique , 1974 .

[18]  T. Tromovitch,et al.  Microscopically controlled excision of skin tumors. , 1974, Archives of dermatology.

[19]  R. Marks,et al.  Squamous cell carcinoma of the skin: Accuracy of clinical diagnosis and outcome of follow‐up in Australia , 1986, The Medical journal of Australia.

[20]  D. Weedon,et al.  Diagnosis of skin cancer in the general population: clinical accuracy in the Nambour survey , 1988, The Medical journal of Australia.

[21]  J. Zitelli,et al.  Mohs micrographic surgery: a cost analysis. , 1998, Journal of the American Academy of Dermatology.

[22]  D. Jones,et al.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.

[23]  A. Kopf,et al.  Scalpel excision of basal cell carcinomas. , 1978, Archives of dermatology.

[24]  D. Brodland,et al.  Surgical margins for excision of primary cutaneous squamous cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[25]  G. Hallock,et al.  Prospective Study of the Accuracy of the Surgeon's Diagnosis in 2000 Excised Skin Tumors , 1998, Plastic and reconstructive surgery.

[26]  A. Rintala Surgical therapy of basal cell carcinoma. Correlation of the macroscopic and microscopic control of excision with recurrence. , 1971, Scandinavian journal of plastic and reconstructive surgery.